hitdisc-20261022-use-case-summary: WF1696 wording corrected to the source's own
Claimed value of Summary of the evidence for use-case-hit-discovery-virtual-screening
Three sources in this store score machine-learning and co-folding methods against docking on the same screening data, and what the numbers say depends on how the negatives were built. On DEKOIS 2.0, whose 79 targets each pair 40 validated actives with 1,200 property-matched decoys selected from ZINC (1:30), the co-folding confidence scores enrich strongly and beat the docking arms. AF3 min-iPAE gives a mean EF1% of 23.15 and Boltz-2 min-iPAE 22.73, against 12.01 for the Glide SP row quoted from another paper, 5.16 for Gnina Vina and 2.94 for TankBind; the best rescoring of a co-folded pose, RTMScore on AF3 poses, reaches 21.34. The authors flag their own Boltz-2 affinity arms (mean EF1% 23.54 and 25.84) as likely over-estimates because Boltz-2 drew affinity data from the same public databases that source DEKOIS 2.0. On GPCRrecent, 16 targets whose first crystal structures were released after 2022 with decoys generated by a conditional recurrent neural network at 1:50, every value falls and the margin narrows: Boltz-2 min-iPAE gives a mean EF1% of 13.96 against 5.02 for Glide SP and 3.65 for Gnina Vina. On the five LIT-PCBA targets where the inactives were experimentally measured, the margin largely disappears: averaged over the five targets Boltz-2 min-iPAE gives EF1% 9.30 and NEF1% 0.100 against Glide SP's 6.79 and 0.079, and on TP53 both Boltz-2 scores give EF1% 0.00 while Protenix ipTM gives 5.00 and Glide SP 3.75. A separate audit of LIT-PCBA reports 323 active training-validation analogue pairs at ECFP4 Tanimoto at or above 0.6 in ALDH1 alone and 2,491 2D-identical inactives shared between training and validation across targets, and concludes that a parameter-free memorisation baseline matches or exceeds published deep-learning results there, so every LIT-PCBA value above carries that limit. Where the negatives are compounds a docking screen already ranked highly and every compound was synthesised and assayed, the ordering changes. On the AmpC list (247 inhibitors among 1,293 tested compounds from a 1.7-billion molecule screen) DOCK3.7 separates binders best, AUC 76.5, against 68.1 for Boltz-2 pIC50 and 60.5 for AF3 L-pLDDT. On the dopamine D4 list (205 binders among 541) docking and Boltz-2 are indistinguishable at the precision printed (both about 71) and AF3 L-pLDDT is worse than random at 46.4. Only on the sigma-2 list (201 binders among 506) does a co-folding score lead, Boltz-2 pIC50 at 83.8 against DOCK3.7's 78.8, with AF3 L-pLDDT at 56.1. In the one blinded prospective challenge, CACHE #3 on the SARS-CoV-2 Nsp3 macrodomain, 23 workflows selected 1,739 compounds that were synthesised and assayed; 28 advanced to hit expansion and 29 confirmed hits scored above 15, four of them judged chemically novel. Twelve of the 23 workflows returned no confirmed hit from their own selection of 41 to 99 compounds. When every workflow was applied to the same merged 1,739-compound library, WF1696, which the article describes as a purely physics-based method, captured 2 of the 4 Tier 1 and 9 of the 25 Tier 2 confirmed hits from 99 predicted actives, which the authors report as did better than any other method in retrieving hits from the collection of all molecules selected in Round 1. Cost bounds all of this: co-folding one protein-ligand pair takes 7.79 to 34.58 seconds per compound on one NVIDIA H100 with pre-computed MSAs, which is why the LIT-PCBA arm covers five targets rather than fifteen. No docking tool was timed on the same hardware, no ligand-similarity or pharmacophore baseline is scored anywhere in this batch, and no result here estimates the hit rate of an untested library.
'Significantly more hits than any other' is what the article says of WF1715's own-selection aggregated score. Of WF1696 it says it 'did better than any other method in retrieving hits from the collection of all molecules selected in Round 1'.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
7 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Claimed field attributes.value Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Previous value Three sources in this store score machine-learning and co-folding methods against docking on the same screening data, and what the numbers say depends on how the negatives were built.
On DEKOIS 2.0, whose 79 targets each pair 40 validated actives with 1,200 property-matched decoys selected from ZINC (1:30), the co-folding confidence scores enrich strongly and beat the docking arms. AF3 min-iPAE gives a mean EF1% of 23.15 and Boltz-2 min-iPAE 22.73, against 12.01 for the Glide SP row quoted from another paper, 5.16 for Gnina Vina and 2.94 for TankBind; the best rescoring of a co-folded pose, RTMScore on AF3 poses, reaches 21.34. The authors flag their own Boltz-2 affinity arms (mean EF1% 23.54 and 25.84) as likely over-estimates because Boltz-2 drew affinity data from the same public databases that source DEKOIS 2.0.
On GPCRrecent, 16 targets whose first crystal structures were released after 2022 with decoys generated by a conditional recurrent neural network at 1:50, every value falls and the margin narrows: Boltz-2 min-iPAE gives a mean EF1% of 13.96 against 5.02 for Glide SP and 3.65 for Gnina Vina. On the five LIT-PCBA targets where the inactives were experimentally measured, the margin largely disappears: averaged over the five targets Boltz-2 min-iPAE gives EF1% 9.30 and NEF1% 0.100 against Glide SP's 6.79 and 0.079, and on TP53 both Boltz-2 scores give EF1% 0.00 while Protenix ipTM gives 5.00 and Glide SP 3.75. A separate audit of LIT-PCBA reports 323 active training-validation analogue pairs at ECFP4 Tanimoto at or above 0.6 in ALDH1 alone and 2,491 2D-identical inactives shared between training and validation across targets, and concludes that a parameter-free memorisation baseline matches or exceeds published deep-learning results there, so every LIT-PCBA value above carries that limit.
Where the negatives are compounds a docking screen already ranked highly and every compound was synthesised and assayed, the ordering changes. On the AmpC list (247 inhibitors among 1,293 tested compounds from a 1.7-billion molecule screen) DOCK3.7 separates binders best, AUC 76.5, against 68.1 for Boltz-2 pIC50 and 60.5 for AF3 L-pLDDT. On the dopamine D4 list (205 binders among 541) docking and Boltz-2 are indistinguishable at the precision printed (both about 71) and AF3 L-pLDDT is worse than random at 46.4. Only on the sigma-2 list (201 binders among 506) does a co-folding score lead, Boltz-2 pIC50 at 83.8 against DOCK3.7's 78.8, with AF3 L-pLDDT at 56.1.
In the one blinded prospective challenge, CACHE #3 on the SARS-CoV-2 Nsp3 macrodomain, 23 workflows selected 1,739 compounds that were synthesised and assayed; 28 advanced to hit expansion and 29 confirmed hits scored above 15, four of them judged chemically novel. Twelve of the 23 workflows returned no confirmed hit from their own selection of 41 to 99 compounds. When every workflow was applied to the same merged 1,739-compound library, WF1696, which the article describes as a purely physics-based method, captured 2 of the 4 Tier 1 and 9 of the 25 Tier 2 confirmed hits from 99 predicted actives, which the authors report as significantly more hits than any other workflow.
Cost bounds all of this: co-folding one protein-ligand pair takes 7.79 to 34.58 seconds per compound on one NVIDIA H100 with pre-computed MSAs, which is why the LIT-PCBA arm covers five targets rather than fifteen. No docking tool was timed on the same hardware, no ligand-similarity or pharmacophore baseline is scored anywhere in this batch, and no result here estimates the hit rate of an untested library. Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed value Three sources in this store score machine-learning and co-folding methods against docking on the same screening data, and what the numbers say depends on how the negatives were built.
On DEKOIS 2.0, whose 79 targets each pair 40 validated actives with 1,200 property-matched decoys selected from ZINC (1:30), the co-folding confidence scores enrich strongly and beat the docking arms. AF3 min-iPAE gives a mean EF1% of 23.15 and Boltz-2 min-iPAE 22.73, against 12.01 for the Glide SP row quoted from another paper, 5.16 for Gnina Vina and 2.94 for TankBind; the best rescoring of a co-folded pose, RTMScore on AF3 poses, reaches 21.34. The authors flag their own Boltz-2 affinity arms (mean EF1% 23.54 and 25.84) as likely over-estimates because Boltz-2 drew affinity data from the same public databases that source DEKOIS 2.0.
On GPCRrecent, 16 targets whose first crystal structures were released after 2022 with decoys generated by a conditional recurrent neural network at 1:50, every value falls and the margin narrows: Boltz-2 min-iPAE gives a mean EF1% of 13.96 against 5.02 for Glide SP and 3.65 for Gnina Vina. On the five LIT-PCBA targets where the inactives were experimentally measured, the margin largely disappears: averaged over the five targets Boltz-2 min-iPAE gives EF1% 9.30 and NEF1% 0.100 against Glide SP's 6.79 and 0.079, and on TP53 both Boltz-2 scores give EF1% 0.00 while Protenix ipTM gives 5.00 and Glide SP 3.75. A separate audit of LIT-PCBA reports 323 active training-validation analogue pairs at ECFP4 Tanimoto at or above 0.6 in ALDH1 alone and 2,491 2D-identical inactives shared between training and validation across targets, and concludes that a parameter-free memorisation baseline matches or exceeds published deep-learning results there, so every LIT-PCBA value above carries that limit.
Where the negatives are compounds a docking screen already ranked highly and every compound was synthesised and assayed, the ordering changes. On the AmpC list (247 inhibitors among 1,293 tested compounds from a 1.7-billion molecule screen) DOCK3.7 separates binders best, AUC 76.5, against 68.1 for Boltz-2 pIC50 and 60.5 for AF3 L-pLDDT. On the dopamine D4 list (205 binders among 541) docking and Boltz-2 are indistinguishable at the precision printed (both about 71) and AF3 L-pLDDT is worse than random at 46.4. Only on the sigma-2 list (201 binders among 506) does a co-folding score lead, Boltz-2 pIC50 at 83.8 against DOCK3.7's 78.8, with AF3 L-pLDDT at 56.1.
In the one blinded prospective challenge, CACHE #3 on the SARS-CoV-2 Nsp3 macrodomain, 23 workflows selected 1,739 compounds that were synthesised and assayed; 28 advanced to hit expansion and 29 confirmed hits scored above 15, four of them judged chemically novel. Twelve of the 23 workflows returned no confirmed hit from their own selection of 41 to 99 compounds. When every workflow was applied to the same merged 1,739-compound library, WF1696, which the article describes as a purely physics-based method, captured 2 of the 4 Tier 1 and 9 of the 25 Tier 2 confirmed hits from 99 predicted actives, which the authors report as did better than any other method in retrieving hits from the collection of all molecules selected in Round 1.
Cost bounds all of this: co-folding one protein-ligand pair takes 7.79 to 34.58 seconds per compound on one NVIDIA H100 with pre-computed MSAs, which is why the LIT-PCBA arm covers five targets rather than fifteen. No docking tool was timed on the same hardware, no ligand-similarity or pharmacophore baseline is scored anywhere in this batch, and no result here estimates the hit rate of an untested library. Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description 'Significantly more hits than any other' is what the article says of WF1715's own-selection aggregated score. Of WF1696 it says it 'did better than any other method in retrieving hits from the collection of all molecules selected in Round 1'. Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: subject hitdisc-20261022-use-case-summary Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Name hitdisc-20261022-use-case-summary: WF1696 wording corrected to the source's own Context-only references | Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows' Version: PMC12892310 (J Chem Inf Model, published 2026-01-21) | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
1 source record and release history
- Herasymenko et al. 2026, J Chem Inf Model (CACHE Challenge #3, Europe PMC full text) · Original source · PMC12892310 (J Chem Inf Model, published 2026-01-21)
Technical metadata and extraction receipts
Stable ID: metadata-correction-af9e1e5f966877013dbf
- areas
- molecular-interactions
- contexts
- research
- field
- attributes.value
- previous value
- Three sources in this store score machine-learning and co-folding methods against docking on the same screening data, and what the numbers say depends on how the negatives were built. On DEKOIS 2.0, whose 79 targets each pair 40 validated actives with 1,200 property-matched decoys selected from ZINC (1:30), the co-folding confidence scores enrich strongly and beat the docking arms. AF3 min-iPAE gives a mean EF1% of 23.15 and Boltz-2 min-iPAE 22.73, against 12.01 for the Glide SP row quoted from another paper, 5.16 for Gnina Vina and 2.94 for TankBind; the best rescoring of a co-folded pose, RTMScore on AF3 poses, reaches 21.34. The authors flag their own Boltz-2 affinity arms (mean EF1% 23.54 and 25.84) as likely over-estimates because Boltz-2 drew affinity data from the same public databases that source DEKOIS 2.0. On GPCRrecent, 16 targets whose first crystal structures were released after 2022 with decoys generated by a conditional recurrent neural network at 1:50, every value falls and the margin narrows: Boltz-2 min-iPAE gives a mean EF1% of 13.96 against 5.02 for Glide SP and 3.65 for Gnina Vina. On the five LIT-PCBA targets where the inactives were experimentally measured, the margin largely disappears: averaged over the five targets Boltz-2 min-iPAE gives EF1% 9.30 and NEF1% 0.100 against Glide SP's 6.79 and 0.079, and on TP53 both Boltz-2 scores give EF1% 0.00 while Protenix ipTM gives 5.00 and Glide SP 3.75. A separate audit of LIT-PCBA reports 323 active training-validation analogue pairs at ECFP4 Tanimoto at or above 0.6 in ALDH1 alone and 2,491 2D-identical inactives shared between training and validation across targets, and concludes that a parameter-free memorisation baseline matches or exceeds published deep-learning results there, so every LIT-PCBA value above carries that limit. Where the negatives are compounds a docking screen already ranked highly and every compound was synthesised and assayed, the ordering changes. On the AmpC list (247 inhibitors among 1,293 tested compounds from a 1.7-billion molecule screen) DOCK3.7 separates binders best, AUC 76.5, against 68.1 for Boltz-2 pIC50 and 60.5 for AF3 L-pLDDT. On the dopamine D4 list (205 binders among 541) docking and Boltz-2 are indistinguishable at the precision printed (both about 71) and AF3 L-pLDDT is worse than random at 46.4. Only on the sigma-2 list (201 binders among 506) does a co-folding score lead, Boltz-2 pIC50 at 83.8 against DOCK3.7's 78.8, with AF3 L-pLDDT at 56.1. In the one blinded prospective challenge, CACHE #3 on the SARS-CoV-2 Nsp3 macrodomain, 23 workflows selected 1,739 compounds that were synthesised and assayed; 28 advanced to hit expansion and 29 confirmed hits scored above 15, four of them judged chemically novel. Twelve of the 23 workflows returned no confirmed hit from their own selection of 41 to 99 compounds. When every workflow was applied to the same merged 1,739-compound library, WF1696, which the article describes as a purely physics-based method, captured 2 of the 4 Tier 1 and 9 of the 25 Tier 2 confirmed hits from 99 predicted actives, which the authors report as significantly more hits than any other workflow. Cost bounds all of this: co-folding one protein-ligand pair takes 7.79 to 34.58 seconds per compound on one NVIDIA H100 with pre-computed MSAs, which is why the LIT-PCBA arm covers five targets rather than fifteen. No docking tool was timed on the same hardware, no ligand-similarity or pharmacophore baseline is scored anywhere in this batch, and no result here estimates the hit rate of an untested library.
- value
- Three sources in this store score machine-learning and co-folding methods against docking on the same screening data, and what the numbers say depends on how the negatives were built. On DEKOIS 2.0, whose 79 targets each pair 40 validated actives with 1,200 property-matched decoys selected from ZINC (1:30), the co-folding confidence scores enrich strongly and beat the docking arms. AF3 min-iPAE gives a mean EF1% of 23.15 and Boltz-2 min-iPAE 22.73, against 12.01 for the Glide SP row quoted from another paper, 5.16 for Gnina Vina and 2.94 for TankBind; the best rescoring of a co-folded pose, RTMScore on AF3 poses, reaches 21.34. The authors flag their own Boltz-2 affinity arms (mean EF1% 23.54 and 25.84) as likely over-estimates because Boltz-2 drew affinity data from the same public databases that source DEKOIS 2.0. On GPCRrecent, 16 targets whose first crystal structures were released after 2022 with decoys generated by a conditional recurrent neural network at 1:50, every value falls and the margin narrows: Boltz-2 min-iPAE gives a mean EF1% of 13.96 against 5.02 for Glide SP and 3.65 for Gnina Vina. On the five LIT-PCBA targets where the inactives were experimentally measured, the margin largely disappears: averaged over the five targets Boltz-2 min-iPAE gives EF1% 9.30 and NEF1% 0.100 against Glide SP's 6.79 and 0.079, and on TP53 both Boltz-2 scores give EF1% 0.00 while Protenix ipTM gives 5.00 and Glide SP 3.75. A separate audit of LIT-PCBA reports 323 active training-validation analogue pairs at ECFP4 Tanimoto at or above 0.6 in ALDH1 alone and 2,491 2D-identical inactives shared between training and validation across targets, and concludes that a parameter-free memorisation baseline matches or exceeds published deep-learning results there, so every LIT-PCBA value above carries that limit. Where the negatives are compounds a docking screen already ranked highly and every compound was synthesised and assayed, the ordering changes. On the AmpC list (247 inhibitors among 1,293 tested compounds from a 1.7-billion molecule screen) DOCK3.7 separates binders best, AUC 76.5, against 68.1 for Boltz-2 pIC50 and 60.5 for AF3 L-pLDDT. On the dopamine D4 list (205 binders among 541) docking and Boltz-2 are indistinguishable at the precision printed (both about 71) and AF3 L-pLDDT is worse than random at 46.4. Only on the sigma-2 list (201 binders among 506) does a co-folding score lead, Boltz-2 pIC50 at 83.8 against DOCK3.7's 78.8, with AF3 L-pLDDT at 56.1. In the one blinded prospective challenge, CACHE #3 on the SARS-CoV-2 Nsp3 macrodomain, 23 workflows selected 1,739 compounds that were synthesised and assayed; 28 advanced to hit expansion and 29 confirmed hits scored above 15, four of them judged chemically novel. Twelve of the 23 workflows returned no confirmed hit from their own selection of 41 to 99 compounds. When every workflow was applied to the same merged 1,739-compound library, WF1696, which the article describes as a purely physics-based method, captured 2 of the 4 Tier 1 and 9 of the 25 Tier 2 confirmed hits from 99 predicted actives, which the authors report as did better than any other method in retrieving hits from the collection of all molecules selected in Round 1. Cost bounds all of this: co-folding one protein-ligand pair takes 7.79 to 34.58 seconds per compound on one NVIDIA H100 with pre-computed MSAs, which is why the LIT-PCBA arm covers five targets rather than fifteen. No docking tool was timed on the same hardware, no ligand-similarity or pharmacophore baseline is scored anywhere in this batch, and no result here estimates the hit rate of an untested library.
- source locator
- Herasymenko et al. 2026, Results 'Trends and Strategies from the Best Performing Computational Workflows'
- review
- method: scope-review; independent-cell-check; reviewer: claude; reviewer note: Claude review agent, independent of the extraction agent; no human review claimed; date: 2026-10-22; method note: Read both sentences in the pinned article: 'significantly more hits' belongs to WF1715 and Figure 6b, not to WF1696.; note: Correction found by the independent review pass of batch use-case-coverage-hitdisc-20261022. The previous value is kept here.; receipt: data/omics/use-case-coverage-hitdisc-20261022/review.json